Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new ...
Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...
In a memo obtained by NPR, acting health secretary Dorothy Fink forbade staff from public communications on most matters ...
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
About half of respondents said the nation should spend more on Medicaid and Medicare — a potential challenge for the Trump ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback